Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Data backs Avastin as second-line treatment
Data backs Avastin as second-line treatment
Data backs Avastin as second-line treatment
Submitted by
admin
on August 18, 2009 - 11:22am
Source:
Fierce Pharma
News Tags:
Roche
Avastin
breast cancer
Genentech
Headline:
Data backs Avastin as second-line treatment
Do Not Allow Advertisers to Use My Personal information
